Announcements

Posted: 2024-07-24

19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting

The 19th Asian Society for Neuro-Oncology (ASNO) Annual Meeting will be held at the One Farrer Hotel, Singapore from 16 – 18 August 2024.

Posted: 2024-06-24

New Impact Factor for Translational Cancer Research: 1.5

We are pleased to announce that Translational Cancer Research (TCR) has attained its latest impact factor update for the 2023 citation year: 1.5.

Posted: 2024-06-14

Translational Cancer Research 2023 CiteScore Released: 2.1

We are pleased to announce that the Translational Cancer Research (TCR) has received its 2023 CiteScore: 2.1, ranking 209 out of 333 journals in the Radiology, Nuclear Medicine and Imaging category.

Posted: 2024-05-13

Join us at the 32nd Annual Meeting of the European Society of Thoracic Surgery

The 32nd Annual Meeting of the European Society of Thoracic Surgery is going to be held in May 26-28, 2024 in Barcelona, Spain: https://ests2024.com/ests2024.

Posted: 2024-01-22

TCR 2023 Annual Report

Greetings from the Editorial Office of TCR!

Posted: 2023-07-05

Translational Cancer Research 2022 CiteScore Released: 1.2

We are pleased to announce that the Translational Cancer Research (TCR) has received its 2022 CiteScore: 1.2, ranking 232 out of 312 journals in the Radiology, Nuclear Medicine and Imaging category.

Posted: 2023-06-30

New Impact Factor for Translational Cancer Research: 0.9

We are pleased to announce that Translational Cancer Research (TCR) has attained its latest impact factor update for the 2022 citation year: 0.9 (Figure 1).

Posted: 2023-04-19

Join us at the 31st Annual Meeting of the European Society of Thoracic Surgery

The 31st Annual Meeting of the European Society of Thoracic Surgery is going to be held in June 4-6, 2023 in Milan, Italy: https://emma.events/ests2023/.

Posted: 2023-03-15

Full implementation of transparent peer review at Translational Cancer Research

With a commitment to openness and accountability, and to increase the level of transparency throughout our peer review process, our editorial office has decided to fully implement the transparent peer review (TPR) process for all new submission from March 15, 2023.

Posted: 2023-03-07

Join us at the 103rd Annual Meeting of American Association for Thoracic Surgery (AATS)

Posted: 2023-01-31

Welcome to join us at the 18^th St. Gallen International Breast Cancer Conference 2023, Vienna, Austria, 15 - 18 March!

The 18^th St. Gallen International Breast Cancer Conference 2023 will be held in Vienna, Austria this year during 15-18 March.

Posted: 2023-01-31

TCR 2022 Annual Report

Greetings from the Editorial Office of TCR!

Posted: 2022-09-30

Testimonials from prestigious Editorial Board Members

Prestigious editorial board members of Translational Cancer Research (TCR) recommend the journal according to their knowledge to TCR and their personal interaction with it. The editorial team appreciate supports from the Editorial Board Members.

Posted: 2022-06-30

New Impact Factor for Translational Cancer Research: 0.496

We are pleased to announce that the Translational Cancer Research (TCR) has attained its latest impact factor update for the 2021 citation year: 0.496.

Posted: 2021-12-18

Translational Cancer Research is indexed in PubMed/PMC: A tremendous step forward

We are delighted to announce that Translational Cancer Research (TCR) has passed the Scientific Quality Review by NLM for PMC. TCR is now indexed in PubMed/PMC, two important and extensive biomedical digital databases, which means publications in TCR will enjoy maximum exposure. All articles published in TCR from 2019 onwards will be available in PubMed/PMC within 1-2 months.

Posted: 2021-11-05

Translational Cancer Research (TCR) is now a member of Committee on Publication Ethics (COPE)

Starting from July 2021, AME Publishing Company is formally recognized a publisher member of Committee on Publication Ethics (COPE) and over 60 AME-published journals become a member of Committee on Publication Ethics (COPE), as part of AME’s commitment to best practice in scholarly publishing. Translational Cancer Research (TCR) is among the list of COPE membership.

Posted: 2021-07-01

New Impact Factor for Translational Cancer Research: 1.241

We are pleased to announce that the Translational Cancer Research (TCR) has attained its latest impact factor update for the 2020 citation year: 1.241.

Posted: 2021-01-18

TCR 2020 Annual Report

Greetings from Editor-in-Chief and Editorial Office of Translational Cancer Research!

Posted: 2020-06-30

New Impact Factor for Translational Cancer Research: 0.986

We are pleased to announce that the Translational Cancer Research (TCR) has attained its latest impact factor update for the 2019 citation year: 0.986.

Posted: 2020-04-29

AME entered an official partnership with Publons to enhance wide-ranging recognition for reviewers

AME Publishing Company entered an official partnership with Publons, a product of Clarivate Analytic Company (which owns Web of Science, EndNote, ScholarOne, among many others), as of April 2020.

Posted: 2020-01-17

TCR Annual Report (2019)

Greetings from Editor-in-Chief and Editorial Office of Translational Cancer Research!

Posted: 2019-10-11

Application of the CARE Guideline as reporting standard in Translational Cancer Research

Translational Cancer Research welcomes case reports which are supposed to report new observations of diseases, clinical findings or novel/unique treatment outcomes relevant to practitioners in the fields of medicine.

Posted: 2019-09-12

Translational Cancer Research (TCR) is going to publish monthly starting in September 2019!

Posted: 2019-06-21

New Impact Factor for Translational Cancer Research: 1.07

Posted: 2019-01-22

TCR Annual Report (2018)

Posted: 2018-01-30

TCR Annual Report (2017)

Posted: 2017-12-06

Welcome to the 2017 Taiwan Society for Therapeutic Radiology and Oncology Conference: “Bring Insight into Impacts” and Both Sides across the Strait Forum

Posted: 2017-11-30